Patents by Inventor Ngoc My Tran

Ngoc My Tran has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 3-methylidenyl-2-indolinone modulators of protein kinase
    Patent number: 6855730
    Abstract: The present invention relates to novel 3-methylidenyl-2-indolinone compounds and physiologically acceptable salts and prodrugs thereof which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.
    Type: Grant
    Filed: March 10, 2003
    Date of Patent: February 15, 2005
    Assignee: Sugen, Inc.
    Inventors: Pen Cho Tang, Li Sun, Todd Anthony Miller, Congxin Liang, Ngoc My Tran, Anh Thi Nguyen, Asaad Nematalla
  • Methods of modulating protein tyrosine kinase function with substituted indolinone compounds
    Publication number: 20040067531
    Abstract: The invention relates to certain indolinone compounds, their method of synthesis, and a combinatorial library consisting of the indolinone compounds. The invention also relates to methods of modulating the function of protein tyrosine kinases using indolinone compounds and methods of treating diseases by modulating the function of protein tyrosine kinases and related signal transduction pathways.
    Type: Application
    Filed: June 11, 2003
    Publication date: April 8, 2004
    Applicant: SUGEN, INC.
    Inventors: Peng Cho Tang, Li Sun, Ngoc My Tran, Anh Thi Nguyen, Asaad Nematalla
  • 3-methylidenyl-2-indolinone modulators of protein kinase
    Publication number: 20040024010
    Abstract: The present invention relates to novel 3-methylidenyl-2-indolinone compounds and physiologically acceptable salts and prodrugs thereof which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.
    Type: Application
    Filed: March 10, 2003
    Publication date: February 5, 2004
    Applicant: Sugen, Inc.
    Inventors: Pen Cho Tang, Li Sun, Todd Anthony Miller, Congxin Liang, Ngoc My Tran, Anh Thi Nguyen, Asaad Nematalla
  • Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
    Patent number: 6642251
    Abstract: The present invention relates to novel geometrically restricted 2-indolinones and physiologically acceptable salts thereof which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.
    Type: Grant
    Filed: January 15, 2003
    Date of Patent: November 4, 2003
    Assignee: Sugen, Inc.
    Inventors: Peng Cho Tang, Todd Anthony Miller, Li Sun, Ngoc My Tran, Asaad Nematalla, Anh Thi Nguyen
  • Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
    Publication number: 20030199510
    Abstract: The present invention relates to novel geometrically restricted 2-indolinones and physiologically acceptable salts thereof which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.
    Type: Application
    Filed: January 15, 2003
    Publication date: October 23, 2003
    Applicant: SUGEN, INC.
    Inventors: Peng Cho Tang, Todd Anthony Miller, Li Sun, Ngoc My Tran, Asaad Nematalla, Anh Thi Nguyen
  • 3-Methylidenyl-2-indolinone modulators of protein kinase
    Patent number: 6531502
    Abstract: The present invention relates to novel 3-methylidenyl-2-indolinone compounds and physiologically acceptable salts and prodrugs thereof which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.
    Type: Grant
    Filed: February 5, 2001
    Date of Patent: March 11, 2003
    Assignee: Sugen, Inc.
    Inventors: Pen Cho Tang, Li Sun, Todd Anthony Miller, Congxin Liang, Ngoc My Tran, Anh Thi Nguyen, Asaad Nematalla
  • Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
    Patent number: 6525072
    Abstract: The present invention relates to novel geometrically restricted 2-indolinones and physiologically acceptable salts thereof which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.
    Type: Grant
    Filed: August 30, 1999
    Date of Patent: February 25, 2003
    Assignee: Sugen, Inc.
    Inventors: Peng Cho Tang, Todd Anthony Miller, Li Sun, Ngoc My Tran, Asaad Nematalla, Anh Thi Nguyen